We treated with Levetiracetam (LEV) patients with ischaemic or haemorrhagic stroke, who had early (ES) or late seizures (LS), to evaluate the efficacy of the drug on both types of seizures, the possibility to avoid their recur-rence, interaction with other AEDs and its tolerability. LEV proved to be an effective and safe treatment of stroke-related seizures, as far as prevention of LS or epilepsy is concerned in patients who had ES (risk factor).
|Translated title of the contribution||Effects of Levetiracetam on stroke-related seizures: An open trial. Preliminary report|
|Number of pages||3|
|Journal||Bollettino - Lega Italiana contro l'Epilessia|
|Publication status||Published - Jul 2004|
ASJC Scopus subject areas
- Clinical Neurology